Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker of Iron Deficiency in Hemodialysis Patients

Research Article

Austin J Nephrol Hypertens. 2015;2(2): 1036.

Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker of Iron Deficiency in Hemodialysis Patients

Mabrouk I Ismail1, Mohamed Fouad1*, Ayman Ramadan2, Hoda Fathy3, Amal Zidan3and Ezzat Mostafa1

1Department of Nepherology, Zagazig University Hospital, Egypt

2Department of Internal medicine, Zagazig University Hospital, Egypt

3Departments of Clinical Pathology, Zagazig University Hospital, Egypt

*Corresponding author: Mohamed Fouad, Department of Nepherology, Zagazig University Hospital, Egypt

Received: December 17, 2014; Accepted: February 09, 2015; Published: February 11, 2015

Abstract

Iron deficiency is often present in Hemodialysis (HD) patients. NGAL is a novel regulator of iron related gene that may contribute to anemia in HD patients. We conducted this study to evaluate the relationship of NGAL and the iron status in HD patients. Prospective cohort study was carried out, in between Dec 2012 to Mar 2014. The total number of the study was 120 hemodialysis patients among them 67 males and 53 females. According to transferrin saturation (TSAT) the eligible participants were divided into two equal subgroups. Group IA: TSAT <20% (iron deficiency). Group IB: TSAT = 20% (without iron deficiency). Additional 60 healthy volunteers as control group (Group II). NGAL levels, indices of anemia, such as ferritin, TSAT and serum iron were measured in all subjects. NGAL level was significantly higher in HD patients than the healthy control group; furthermore, HD patients with TSAT < 20 had lower NGAL values than HD patients with TSAT = 20. Surprisingly NGAL values significantly increased to comparable level after correction of iron deficiency by i.v. iron administration. The mean value of S. iron, S. transferrin, TSAT and S. ferritin were significantly higher in group IB than group IA. NGAL cutoff level of =461 ng/ml had a greater sensitivity and specificity than ferritin level of <200 ng/ml and TSAT level of < 20% in identifying iron deficiency among HD patients. All study parameters were correlated with NGAL level: Only SCr (P<0.05), ALP (P<0.01), HB (P<0.001), hsCRP (P=<0.001), S. Iron (P<0.001), TSAT (P<0.001) and ferritin (P<0.001) were positively correlated with NGAL level. The potential use of NGAL measurement may be valuable as a novel marker of iron status among hemodialysis patients.

Keywords: NGAL; Hemodialysis; Iron deficiency anemia; Iron status

Introduction

Anemia is defined as a reduction in one or more of the major red blood cell measurements; hemoglobin concentration, hematocrit, or red blood cell count. The World Health Organization defines anemia as a hemoglobin level less than 13 g/dL in men and post-menopausal women, and less than 12 g/dL in pre-menopausal women [1]. Anemia is a universal complication among patients with End Stage Renal Disease (ESRD), due mainly to impaired erythropoietin synthesis by the diseased kidneys, and an absolute or functional iron deficiency [2]. Other contributing factors include inflammation, regular blood loss, haemolysis, vitamin deficiency, hyperparathyroidism and medications [3].

The Kidney Disease Outcomes Quality Initiative (K/DOQI) anemia work groups suggest that serum ferritin and the TSAT should be considered primary tools in the assessment of iron status in nephropathic subjects; in particular, serum ferritin levels of <100 ng/mL in pre-dialysis chronic kidney disease (CKD) patients or<200 ng/mL in chronic HD patients, and/or TSAT values <20% (in both groups) should reflect an underlying condition of low iron deposits, thus being suggested as cut-off values for deciding upon opportune therapeutic strategies [4].

Serum ferritin was a reliable index of iron storage in HD patients. This protein is an acute-phase reactant, is markedly influenced by malnutrition and has important gender differences, thus making it a less than an ideal tool for identifying iron deficiency. For example, the presence of inflammation can explain the apparent paradoxical coexistence of high ferritin (>500 ng/mL) and low TSAT (<20%) levels frequently found in HD patients [5]. Although TSAT may also be influenced by concomitant conditions, such as reduced transferrin synthesis, inflammation or daily fluctuations, it appears to indicate iron stores in HD patients more reliably than serum ferritin [6].

NGAL is a novel iron-carrier protein [10] and seems to be one of the earliest biomarker of acute kidney injury [11], and also NGAL represents a novel predictive biomarker for CKD and its outcomes [12].

However, reports have implicated NGAL upregulation as a mechanism that contributes to anemia in the setting of chronic inflammation. In experimental models, systemic and medullary NGAL has been demonstrated to induce inhibition of erythropoiesis through induction of apoptosis and arrest of differentiation of erythroid progenitor cells [13].

The aim of the present study is to assess the relationships of NGAL and iron balance, and its utility as a biomarker of iron deficiency in in HD patients

Patients and Methods

Study design and population

This prospective cohort study was carried out in hemodialysis unit of the Zagazig university hospital, in between Dec 2012 to Mar 2014; the aim of the study was explained to all participants and all of them gave informed consent to participate in this study in compliance with the local Institutional Ethics Committee and conformed to the Helsinki Declaration.

Eligible participants included patients on maintenance hemodialysis for at least 1 year. Participants were excluded from the study if suffered from the recent history of bleeding, malignancy, liver diseases, thyroid disorders, infectious diseases, alterations in leukocyte count and/or treatment with steroids or immunosuppressive medication.

Demographic information was collected, the total number of the study was 120 hemodialysis patients among them 67 males and 53 females (1.3:1), on maintenance hemodialysis three times weekly using 3.5 mEq/l dialysate calcium, duration of each dialysis was 4 hours, protocols were not changed during the study with adequate dialysis treatment (Kt/V>1.2).

All subjects had been dry-weight, stable for at least 2 months before the study was started and had achieved a normotensive edema free All subjects had been dry-weight, stable for at least 2 months before the study was started and had achieved a normotensive edemafree state. All HD patients had been on recombinant erythropoietin therapy for at least 6 weeks and none had received intravenous iron administration or packed red cell transfusion in the 2 months preceding the start of the study. The main causes of ESRD were chronic glomerulonephritis 33 (27.5%), diabetic nephropathy24 (20%), interstitial nephropathy 18 (15%), unknown 17 (14%), hypertension 15 (12.5%) and obstructive uropathy 13 (11%).

Iron deficiency was defined as TSAT <20% [4]. Accordingly the eligible participants in this study were divided into two subgroups.

Group IA: TSAT <20% (iron deficiency), 60 subjects (27 males and 33females, their age ranged from 38 years to 68 years (mean 51.3 + 9.9 y) Group IB: TSAT = 20% (without iron deficiency), 60 subjects (39 males and 21 females their age ranged from 40 years to 67 years (mean 51.8 + 8 y)

Group II: Control group was selected of healthy 60 subjects with comparable age, sex to HD patients, for assessment of body iron status. They were on a regular diet without consumption supplementary iron drugs

Follow up

Group IA: TSAT <20% (iron deficiency), were given IV iron infusion 200–500 mg during hemodialysis session, up to correction of iron deficiency (Corrected group IA)

Laboratory measurements

Peripheral venous blood samples were taken in the midweek interdialytic day. All patients were subjected laboratory analysis for complete blood picture (CBC) including haemoglobin (HB) (g/ dl), haematocrit % (HCT), uric acid, fasting blood sugar, serum albumin, blood urea nitrogen (BUN), creatinine (SCr), serum alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), Ca, P , intact parathyroid hormone (i-PTH) and high-sensitivity C-reactive protein (hsCRP), according to standard methods used in the routine clinical laboratory. Iron balance was assessed by measuring the total serum iron, serum transferrin, serum ferritin and Transferrin Saturation (TSAT) calculated according to the following formula: (serum iron/serum transferrin) ×70. 9.

NGAL was measured in the blood using the Enzyme linked immunosorbent assay (ELISA) commercially available kit (BioVendor. Product NO. RD191102200R. Czech Republic), according to the manufacturer’s instructions. All measurements were made blind, in triplicate. NGAL levels were expressed as ng/mL.

Statistical analysis

Data were collected, entered, analyzed and presented as means standard deviations, analysis of variance (ANOVA and LSD tests). The correlation between variables is calculated using the Pearson’s and the Spearman correlation tests. Chi square (?2) test and the criterion for statistical significance were set at P< 0.05. All calculations were carried out using a standard statistical package (SPSS version19. Inc. in Chicago, USA).

Results

Demographic data and characteristic of study

NGAL level was significantly higher in HD patients than the healthy control group; furthermore, HD patients with TSAT < 20 (Group IA) had lower NGAL values than HD patients with TSAT = 20 (Group IB). There were no significant differences in between the 3 groups regarding age, gender and WBC. Really the mean value of SCr, urea and Ca x P ratio were significantly higher in HD patients than the healthy control group. S albumin was significantly lower in HD patients than the healthy control group. hsCRP significantly higher in HD patients than the healthy control group, furthermore hsCRP was significantly higher in group IA than group IB. The mean value of HB and HCT were significantly lower in HD patients than the healthy control group, furthermore HB and HCT were significantly lower in group IA than group IB. Finally S. iron, S. transferrin, TSAT and S. ferritin were significantly higher in group IB than group IA. (Table 1)